SRC-3 Knockout Attenuates Myocardial Injury Induced by Chronic Intermittent Hypoxia in Mice

Wanyu Wang1, Hongbo Gu2, Weihua Li3

  • 1Department of Pulmonary and Critical Care Medicine of the First Affiliated Hospital of XiaMen University, The Third Clinical Medical College of Fujian Medical University, Teaching Hospital of Fujian Medical University, Xiamen, China.

Insights

Chronic intermittent hypoxia (CIH), a model for sleep apnea syndrome, causes cardiac damage. Knocking out SRC-3 protein significantly reduces this CIH-induced heart injury by mitigating oxidative stress and inflammation.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Sleep Medicine

Background:

  • Sleep apnea syndrome (SAS) is linked to cardiovascular complications.
  • Chronic intermittent hypoxia (CIH) is a key pathological feature of SAS.
  • The role of SRC-3 in CIH-induced cardiac dysfunction requires elucidation.

Purpose of the Study:

  • To investigate the impact of CIH on cardiac function in mice.
  • To determine the role of SRC-3 in the development of CIH-induced myocardial injury.
  • To explore the molecular mechanisms underlying SRC-3's involvement in cardiac damage.

Main Methods:

  • Utilized a mouse model of chronic intermittent hypoxia (CIH) for 12 weeks.
  • Employed qRT-PCR, enzymatic assays, immunohistochemistry (IHC), transmission electron microscopy (TEM), and TUNEL staining.
  • Compared wild-type mice with SRC-3 knockout (SRC3-KO) mice under normoxic and CIH conditions.

Main Results:

  • CIH induced cardiac damage, evidenced by increased heart-to-body weight ratio, elevated oxidative stress markers (MDA, NOS, NO), inflammation (NF-κB), and apoptosis.
  • SRC-3 knockout (SRC3-KO) mice exhibited ameliorated cardiac damage, reduced oxidative stress and inflammation, and decreased apoptosis compared to CIH wild-type mice.
  • CIH upregulated specific genes (e.g., 11HSD2, COX-2, NOX2, HIF-1α, IL-1β, IL-6, iNOS, TNF-α, PC-1, TGF-β), with SRC-3 KO partially attenuating these changes.

Conclusions:

  • CIH significantly contributes to cardiac damage via oxidative stress and inflammation.
  • SRC-3 plays a critical role in mediating CIH-induced myocardial injury.
  • Targeting SRC-3 may offer a therapeutic strategy to protect against cardiac dysfunction in sleep apnea syndrome.

Related Concept Videos